These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 1683405)
1. The case for alpha 1-adrenoceptor antagonists as first-line antihypertensive agents. Elliott HL J Hum Hypertens; 1991 Aug; 5(4):309-11. PubMed ID: 1683405 [No Abstract] [Full Text] [Related]
2. [Orthostatic hypotension in patients with antihypertensive combination therapy]. Holzgreve H MMW Fortschr Med; 2009 Jun; 151(26-29):29-30. PubMed ID: 19739543 [No Abstract] [Full Text] [Related]
3. The value of alpha-blockers in the management of hypertension: a practical view. McInnes GT J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406 [No Abstract] [Full Text] [Related]
6. [Orthostatic hypotension with syncope--a problem of hypertensive therapy in the aged]. Trenkwalder P; Lydtin H Z Gerontol; 1993; 26(4):297-301. PubMed ID: 8212801 [TBL] [Abstract][Full Text] [Related]
7. The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension. Warren JB; Dollery CT J Hypertens Suppl; 1988 Dec; 6(2):S43-9. PubMed ID: 2906700 [TBL] [Abstract][Full Text] [Related]
8. Orthostatic hypotension: how to avoid it during antihypertensive therapy. Rieckert H Am J Hypertens; 1996 Nov; 9(11):155S-159S. PubMed ID: 8931848 [TBL] [Abstract][Full Text] [Related]
9. Hypertension, insulin, and alpha 1-blockade. Weidmann P; Ferrari P J Clin Pharmacol; 1993 Sep; 33(9):895-9. PubMed ID: 7901245 [No Abstract] [Full Text] [Related]
10. Q: Should alpha-blockers ever be used as antihypertensive drugs? Rossitto G; Kamath G; Messerli FH Cleve Clin J Med; 2010 Dec; 77(12):884-8. PubMed ID: 21147942 [No Abstract] [Full Text] [Related]
11. [Management of arterial hypertension in children (author's transl]. Balboa de Paz F; Rubio Roldán LA; Sánchez Díaz JI An Esp Pediatr; 1981 Dec; 15(6):573-80. PubMed ID: 6121529 [No Abstract] [Full Text] [Related]
12. Benign prostatic hyperplasia: maximizing treatment with alpha blockers. Lowenthal DT; Flannery M; Mader SL; Nelson RP Geriatrics; 1998 Oct; 53 Suppl 2():S4-28. PubMed ID: 9789482 [No Abstract] [Full Text] [Related]
14. [Choice of antihypertensive agent--insignificant role of doxazosin (Alfadil). How are evidence-based recommendations implemented?]. Gustafsson LL Lakartidningen; 2004 Jan; 101(3):228-9. PubMed ID: 14763097 [No Abstract] [Full Text] [Related]
15. [General principles of antihypertensive treatment]. Lagrue G; Weil B; Buisson C Sem Hop; 1974 Feb; 50(8):561-6. PubMed ID: 4152683 [No Abstract] [Full Text] [Related]
16. Overview of alpha 1-adrenoceptor antagonism and recent advances in hypertensive therapy. Veelken R; Schmieder RE Am J Hypertens; 1996 Nov; 9(11):139S-149S. PubMed ID: 8931846 [TBL] [Abstract][Full Text] [Related]
17. [Alfadil--positive documentation when it comes to safety is missing]. Furberg C Lakartidningen; 2003 Dec; 100(51-52):4329; discussion 4330. PubMed ID: 14756103 [No Abstract] [Full Text] [Related]
19. Overview of Alpha-blockers in Hypertension: Reappraisal of Perspectives. Panchanatham M; Shah SN J Assoc Physicians India; 2014 Sep; 62(9 Suppl):5-8. PubMed ID: 26245035 [No Abstract] [Full Text] [Related]
20. [Alpha-receptor blocking agents and centrally acting antihypertensive agents]. de Leeuw PW Ned Tijdschr Geneeskd; 1988 Apr; 132(14):611-4. PubMed ID: 2896303 [No Abstract] [Full Text] [Related] [Next] [New Search]